Results 101 to 110 of about 841 (164)

Key biomarkers and latent pathways of dysferlinopathy: Bioinformatics analysis and in vivo validation. [PDF]

open access: yesFront Neurol, 2022
Xie Y   +7 more
europepmc   +1 more source

Serum metabolomic signatures of patients with rare neurogenetic diseases: an insight into potential biomarkers and treatment targets. [PDF]

open access: yesFront Mol Neurosci
Wijekoon N   +12 more
europepmc   +1 more source

Alternations of NF-κB Signaling by Natural Compounds in Muscle-Derived Cancers. [PDF]

open access: yesInt J Mol Sci, 2023
Radzka J   +5 more
europepmc   +1 more source

Limb girdle muscular dystrophy type 2A in India: A study based on semi-quantitative protein analysis, with clinical and histopathological correlation

open access: yes, 2010
Background : Limb girdle muscular dystrophy (LGMD) type 2A is caused by mutation in the gene encoding for calpain-3 resulting in total or partial loss of protein. Diagnosis of LGMD2A, the most prevalent form of LGMD, is established by analyzing calpain-3
Jha, Prerana   +8 more
core  

Progress on cell therapy for skeletal muscle disorders. [PDF]

open access: yesAdv Drug Deliv Rev
Azzag K, Perlingeiro RCR.
europepmc   +1 more source

Integrating Machine Learning into Myositis Research: a Systematic Review. [PDF]

open access: yesClin Rev Allergy Immunol
Juarez-Gomez C   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy